Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Heartflow (HTFL) Liabilities and Shareholders Equity (2024 - 2025)

Heartflow has reported Liabilities and Shareholders Equity over the past 2 years, most recently at $359.5 million for Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity rose 202.81% year-over-year to $359.5 million; the TTM value through Dec 2025 reached $1.0 billion, up 744.05%, while the annual FY2025 figure was $359.5 million, 202.81% up from the prior year.
  • Liabilities and Shareholders Equity for Q4 2025 was $359.5 million at Heartflow, down from $364.4 million in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $364.4 million in Q3 2025 and troughed at $118.7 million in Q4 2024.